Literature DB >> 11995904

Intestinal coinfection with numerous Giardia trophozoites and Vibrio cholerae in hospitalized children with watery diarrhea.

R Zerpa1, L Huicho.   

Abstract

During the recent cholera epidemic which affected Peru and other Latin American countries, fresh stool samples of 100 hospitalized children were assessed February through April 1991. The children had been admitted because of profuse watery diarrhea. The microbiologic study of wet mount preparations showed curved bacteria suspicious for cholera agent and confirmed afterward to be Vibrio cholerae 01 scrotype Inaba. In 30% of such cases, besides the curved bacteria, a strikingly large number of trophozoites of Giardia intestinalis were observed. The same samples studied by permanent stains confirmed the presence of Giardia trophozoites. To our knowledge, the association of Giardia with serious epidemic cholera infection has not been previously described. All patients were admitted because of severe dehydration requiring intravenous fluid replacement, which might suggest a synergistic role for the above-noted coinfection. Adequately designed case-control studies are needed to ascertain the frequency and the pathophysiologic and clinical significance of such an unusual association.

Entities:  

Mesh:

Year:  1995        PMID: 11995904     DOI: 10.1580/1080-6032(1995)006[0167:icwngt]2.3.co;2

Source DB:  PubMed          Journal:  Wilderness Environ Med        ISSN: 1080-6032            Impact factor:   1.518


  2 in total

1.  Diarrheagenic pathogens in polymicrobial infections.

Authors:  Brianna Lindsay; T Ramamurthy; Sourav Sen Gupta; Yoshifumi Takeda; Krishnan Rajendran; G Balakrish Nair; O Colin Stine
Journal:  Emerg Infect Dis       Date:  2011-04       Impact factor: 6.883

2.  Clinical features, risk factors, and impact of antibiotic treatment of diarrhea caused by Shigella in children less than 5 years in Manhiça District, rural Mozambique.

Authors:  Delfino Vubil; Sozinho Acácio; Llorenç Quintò; Clara Ballesté-Delpierre; Tacilta Nhampossa; Karen Kotloff; Myron M Levine; Pedro Alonso; James P Nataro; Tamer H Farag; Jordi Vila; Inacio Mandomando
Journal:  Infect Drug Resist       Date:  2018-10-31       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.